Bill > HR4388

This bill seeks to repeal sections 319F-3 and 319F-4 of the Public Health Service Act, which are part of the Public Readiness and Emergency Preparedness (PREP) Act. The bill argues that the existing liability shields for pharmaceutical manufacturers during public health emergencies have undermined public trust and accountability, and that citizens should have the right to seek legal redress for injuries. By repealing these sections, the bill would remove the legal immunity that pharmaceutical companies currently have for products developed, administered, or distributed during emergency situations. The legislation would rescind unobligated balances in the Covered Countermeasure Process Fund and ensure that individuals can pursue civil remedies under federal or state law for injuries related to drugs, devices, biological products, or countermeasures. The bill's provisions would apply to both pending legal actions and new claims filed on or after the date of enactment, while maintaining a severability clause that ensures the rest of the act remains valid even if a specific provision is found to be invalid.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/4388/all-info